TwinStrand Biosciences logo

TwinStrand Biosciences

twinstrandbio.com

TwinStrand Biosciences develops Duplex Sequencing technology that uses error-corrected DNA sequencing to detect ultra-low-frequency genomic variants missed by conventional next-generation sequencing. Its technology supports researchers studying applications such as residual cancer, mutation signatures and genetic toxicology, with the aim of improving human health and accelerating scientific discovery.

Facts

HQ
Seattle, WA, US
Sectors
Biotechnology Research
Type
Corporation Seattle business license
Employees
51–200
Registered name
TwinStrand Biosciences Inc Seattle business license
Stage
Series B
Members see funding amounts.
.

Is this your organization? Claim it

Elon Musk's Starlink swagger, SpaceX vs. the cloud giants, and Seattle’s tech universe revisited

This week: SpaceX reports its first quarter as a public company, and Elon Musk says Starlink could deliver a majority of the world's internet within a decade, leveraging production facilities in Redmond. Musk also explains the company's data center ambitions, calling terrestrial infrastructure a trivial problem next to reusable rockets. Plus: we bring two Washington tech universe posters into the studio, 17 years apart. The 2009 original turns up gems including Boeing's unlikely connection to Classmates.com, a 1990s forerunner to Facebook. The 2009 poster also brings back memories of Teledesic, the Craig McCaw venture backed by Bill Gates that tried…

People

  • Jesse Salk
    Jesse Salk Co-founder and CEO
  • Ron Andrews Executive, Chief Executive Officer and Director

Online